Dr Ashutosh Ojha
Reader, Internal Medicine
17 Feb2016Dr A Ojha
 Clinical complex characterized by a number
of renal and extra renal features.The most
prominent being.
 Proteinuria of > 3.5 g/d
 Hypoalbuminaemia
 Oedema
 Hyperlipidaemia
 Hypercoagulability.
17 Feb2016Dr A Ojha
 Key component is proteinuria
◦ Results from altered permeability of glomerular
filtration barrier(GBM,podocytes& their slit
diaphragm) for proteins
◦ All other metabolic complications are secondary to
urine protein loss.
17 Feb2016Dr A Ojha
Proteinuria Loss of lipid
metabolism
Sr Albumin regulating
protein
Oncotic pressure Oedema
Hepatic lipoprotein synthesis
Hyperlipdaemia
17 Feb2016Dr A Ojha
 Altered level of Urinary loss of
protein C and S Antithrombin III
 Hyperfibrinogenaemia
 Impaired fibrinolysis
  Platelet aggregability
Hypercoagulability
Peripheral arterial and
venous thrombosis
Renal vein thrombosis
Pulmonary embolism
17 Feb2016Dr A Ojha
 Other metabolic complications.
◦ Protein malnutrition
◦ Iron resistant microcytic hypochromic anaemia
◦ Hypocalcaemia
◦ Vit D deficiency
◦ Secondary hypoparathyroidism
◦  thyroxin levels
◦  IgG
17 Feb2016Dr A Ojha
 Damage to GBM
o  Number & size of pores
Passage of more and larger
proteins
o  in fixed negatively charged
components
( Repel negatively charged protein
molecules )
17 Feb2016Dr A Ojha
17 Feb2016Dr A Ojha
 6 entities account for >90% in adults
◦ Minimal change disease(MCD)
◦ Focal & segmental glomerulosclerosis(FSGS)
◦ Membranous glomerulopathy.
◦ Membrnoproliferative GN (MPGN).
◦ Diabetic nephropathy.
◦ Amyloidosis
17 Feb2016Dr A Ojha
 Systemic vasculitis eg-SLE
 Drugs
◦ Penicillamine
◦ Captopril
◦ Gold
◦ Cadmium
 Allergic reactions
◦ Pollens
◦ Bee sting
17 Feb2016Dr A Ojha
 History.
◦ Frothy urine –heavy proteinuria
◦ Oedema-Periorbital,arms.ascites,genital oedema.
◦  BP in some.
◦ Features of underlying disease viz SLE,DM
◦ Rule out
 Primary cardiac failure
 Chronic liver disease
17 Feb2016Dr A Ojha
 Diagnosis established by
◦ 24 hr urinary protein >3.5g/day
◦ Sr Albumin <3g/dl
17 Feb2016Dr A Ojha
  Cholesterol,  LDL,  triglycerides
  Urea, Creatinine ---- progressive disease
 Urine microscopy—RBC,RBC casts
 Throat swab Streptococcal infection
 ASO titer
 C3 level-immune complex mediated
 ANA
 HBsAg&HCAntibodies
 Cryoglbulinaemia

17 Feb2016Dr A Ojha
 Sr electrophoresis - MM
  Blood glucose.—DM
 Selective proteinuria—MCD,diabetic
nephropathy,amyloidosis.
 Non selective proteinuria—Diffuse
proliferative GN
17 Feb2016Dr A Ojha
 Gradual onset of acute renal failure
 No obvious cause of acute renal failure
 Heavy proteinuria
 Significant haematuria
 Clinical evidence or history of systemic
disease
 Prolonged oliguria
17 Feb2016Dr A Ojha
 Not required in
◦ Young children with highly selective proteinuria,no
HTN,no red cells or red cell casts in urine
◦ Long standing insulin dependent diabetes mellitus
◦ On drugs like penicillamine.
17 Feb2016Dr A Ojha
 Specific treatment of underlying cause.
 Drugs- immunosuppressive therapy.
 General measures to control proteinuria.
 General measures to control complications.
17 Feb2016Dr A Ojha
 80% cases < 16yrs, 20% cases in adults.
 Peak incidence 6-8yrs
 Idiopathic.
 Occurrence after URTI, immunization.
  incidence in HLA B12.
 May be associated with interstitial nephritis,
lymphomas.
17 Feb2016Dr A Ojha
 High mol wt proteinuria.
 Benign urinary sediment.
 Microscopic haematuria in 20-30% cases.
 HTN & RF -----rare
17 Feb2016Dr A Ojha
 Glomerular size & structure – normal in light
microscopy.
 Immunoflorescense studies –neg for Ig & C3
 Electron microscopy
 Diffuse effacement of foot processes of
visceral epithelial cells.
17 Feb2016Dr A Ojha
17 Feb2016Dr A Ojha
 Highly steroid responsive .
 Excellent prognosis.
 Spontaneous remission in 30-40% children.
 Remission with 8 wks of high dose
glucocorticoids in 90% of children, 50% of
adults.
17 Feb2016Dr A Ojha
Dose
 Children: 60 mg/mt2/day x 4 wks
40 mg/mt2/day x 4 wks
Adults: 1.15mg/kg/day x 4 wks
1mg/kg/day x 4 wks
 50% relapse fallowing withdrawal.
17 Feb2016Dr A Ojha
 Relapse during / shortly after withdrawal
 Relapse - >3 / yr
Cyclophosphamide- 2-3 mg/ kg /day 8 –12
wks or
Chlormabucil- 0.1-0.2 mg/ kg /day 8 –12 wks
 Side effects-infertility, cystitis, alopecia,
infections, sec malignancies.
 Cyclosporin can be tried in those resistant to
above .
17 Feb2016Dr A Ojha
 Sclerosis with hyalinosis involving portions of
< 50% glomeruli in a tissue section.
 1/3 cases of nephrotic syndrome in males.
 Proteinuria with HTN and mild renal
insufficiency.
17 Feb2016Dr A Ojha
17 Feb2016Dr A Ojha
 Spontaneous remission rare.
 Prognosis poor.
 Drug therapy unsatisfactory.
 Renal transplant.
17 Feb2016Dr A Ojha
 30-40% of NS in adults.
 Rare in children.
 Peak incidence 30-50 yrs.
 1/3 rd assocition with systemic diseases like
SLE, infections, malignancy, HBV, drugs.
17 Feb2016Dr A Ojha
17 Feb2016Dr A Ojha
 Light microscopy- diffuse thickening of GBM
with e/o cellular infiltration.
 Electron microscopy- immune deposits of IgG
& C3
17 Feb2016Dr A Ojha
 Proteinuria- non selective
 Microscopic hematuria in 50%.
 RBC casts, leukocytes, macroscopic hematuria
are rare.
 HTN 10-30%.
 40% remit spontaneously, 10-20% slowly
progressive ESRD, others remit & relapse.
17 Feb2016Dr A Ojha
 Steroids- unsatisfactory.
 Cytotoxic drugs- some benefit.
17 Feb2016Dr A Ojha
 Features
-Thickening of GBM
- proliferative changes.
-diffuse increase in mesangial cells
and matrix.
-immune deposits- C3, IgG, IgM,
IgA.
17 Feb2016Dr A Ojha
 In association with
-IE
-HIV
-HBV, HCV
-Cryoglobulinaemia
-Lymphoma
17 Feb2016Dr A Ojha
 Heavy proteinuria
 Active urinary sediment
 Normal to mildly impaired renal function.
 Course- benign to ESRD.
 No effective treatment.
17 Feb2016Dr A Ojha
 ACE inhibitors- act by ↓ intraglomerular
pressure and prevent hemodynamically
mediated focal segmental glomerulosclerosis.
Specially in DM, FSGS.
 NSAIDS- act by altering glomerular
hemodynamics& permeability.
17 Feb2016Dr A Ojha
 Edema- salt restriction 1-2 gms/ day
 Loop diuretics
 Hyperlipidaemia- statins
 Thromboembolism- anticoagulation.
 Malnutrition- ? High protein diet.
 Vitamins D supplements
17 Feb2016Dr A Ojha
Thank You
17 Feb2016Dr A Ojha
 Contact-9719713786
 ashutosh8116@yahoo.com
 sumitranikentanpatna@gmail.com
17 Feb2016Dr A Ojha

More Related Content

PPTX
Polycythemia
PPTX
Aplastic anemia
PPT
Polycythemai vera and Essential Thrombocytosis
PPT
Aplastic anemia
PPTX
Aquired aplastic anemia
PPTX
Aplastic anemia 2011
PPT
Making the diagnosis in hematology part 2
PPTX
Aplastic anemia
Polycythemia
Aplastic anemia
Polycythemai vera and Essential Thrombocytosis
Aplastic anemia
Aquired aplastic anemia
Aplastic anemia 2011
Making the diagnosis in hematology part 2
Aplastic anemia

What's hot (20)

PPT
Aplastic anemia
PDF
Aplastic anemia in children 2021
PPTX
Hemolytic anemia case
PPTX
Aplastic anemia
PPTX
Polycythemia iquin
PPTX
Aplastic anemia -medical information (definition,management, diagnosis, medic...
PPTX
Aplastic anemia
PPTX
Aplastic anemia
PPTX
Aplastic anemia
PPT
Pancytopenia Approach
PPTX
polycythemia
PPTX
Polycythemia vera
PPTX
Platelets disorders
PPTX
Cytopenia
PPTX
Aplastic anemia
PPT
Polycythemia
PPTX
Aplastic anaemia
PPTX
APPROACH TO PANCYTOPENIA
PPTX
Polycythemia vera rumana
Aplastic anemia
Aplastic anemia in children 2021
Hemolytic anemia case
Aplastic anemia
Polycythemia iquin
Aplastic anemia -medical information (definition,management, diagnosis, medic...
Aplastic anemia
Aplastic anemia
Aplastic anemia
Pancytopenia Approach
polycythemia
Polycythemia vera
Platelets disorders
Cytopenia
Aplastic anemia
Polycythemia
Aplastic anaemia
APPROACH TO PANCYTOPENIA
Polycythemia vera rumana
Ad

Similar to Nephrotic syndrome Undergaraduate (20)

PPTX
Nephrotic syndrome final shivaom
PDF
Aplastic anemia
PPTX
diabeteskidneydisease-130922054028-phpapp02.pptx
PPTX
Haematuria
PPTX
Nephrotic syndrome
DOCX
Hematuria.docx
PPT
NEPHROTIC SYNDROME
PPT
Nephrology - ARCHER USMLE STEP 3
PDF
Liver cirrhosis
PPTX
Anemia
PPTX
Approach to glomerular disease.pkuwkkptx
PPTX
Nephrotic syndrome.pptx dkslflfdf'dsff;wle
PPTX
nephroticsyndromeabhay-copy-140910103817-phpapp02 (1).pptx
PPTX
Nephro pathological correlation
PPTX
Nephrotic & Nephritic Syndromes in Children.pptx
PPTX
Immune &; non immune hemolytic states- kananura keneth
PPTX
ANEMIA IN DIABETES MELLITUS
PPTX
Multiple Myeloma (Case presentation)
PPT
Nephrology e tutoring2
PPT
Nephrology 2,09
Nephrotic syndrome final shivaom
Aplastic anemia
diabeteskidneydisease-130922054028-phpapp02.pptx
Haematuria
Nephrotic syndrome
Hematuria.docx
NEPHROTIC SYNDROME
Nephrology - ARCHER USMLE STEP 3
Liver cirrhosis
Anemia
Approach to glomerular disease.pkuwkkptx
Nephrotic syndrome.pptx dkslflfdf'dsff;wle
nephroticsyndromeabhay-copy-140910103817-phpapp02 (1).pptx
Nephro pathological correlation
Nephrotic & Nephritic Syndromes in Children.pptx
Immune &; non immune hemolytic states- kananura keneth
ANEMIA IN DIABETES MELLITUS
Multiple Myeloma (Case presentation)
Nephrology e tutoring2
Nephrology 2,09
Ad

More from Dr Ashutosh Ojha (15)

PDF
Thyroid and pregnancy
PDF
Dr Ashutosh Ojha Shiv Narayan Singh memorial oration 2020
PPTX
Fever with delirium apicon
PPTX
Scrub Typhus Recent advances
PPTX
Neurogenic bladder UG & PG
PPTX
Chronic Renal Failure (UG)
PPT
Asthama ug ix term
PPTX
Enteric fever ug
PPTX
Pericardial disease Undergaraduate
PPT
Rabies prevention
PPT
Basics of stroke(CVA) Management
PPT
Anemia Indian scenario In Chronic Kidney Disease Patients
PPT
Alcohal withdrwal syndrome-Inpatient Management ppt
PPTX
Dialysis basics
PPTX
Intradialytic hypotension & Its Managemnet
Thyroid and pregnancy
Dr Ashutosh Ojha Shiv Narayan Singh memorial oration 2020
Fever with delirium apicon
Scrub Typhus Recent advances
Neurogenic bladder UG & PG
Chronic Renal Failure (UG)
Asthama ug ix term
Enteric fever ug
Pericardial disease Undergaraduate
Rabies prevention
Basics of stroke(CVA) Management
Anemia Indian scenario In Chronic Kidney Disease Patients
Alcohal withdrwal syndrome-Inpatient Management ppt
Dialysis basics
Intradialytic hypotension & Its Managemnet

Recently uploaded (20)

PPTX
A Detailed Physiology of Endocrine System.pptx
PPTX
ACUTE PANCREATITIS combined.pptx.pptx in kids
PPTX
Approach to Abdominal trauma Gemme(COMMENT).pptx
PDF
Seizures and epilepsy (neurological disorder)- AMBOSS.pdf
PPT
BONE-TYPES,CLASSIFICATION,HISTOLOGY,FRACTURE,
PPTX
Geriatrics_(0).pptxxvvbbbbbbbnnnnnnnnnnk
PPTX
Nutrition needs in a Surgical Patient.pptx
PPTX
Indications for Surgical Delivery...pptx
PPTX
المحاضرة الثالثة Urosurgery (Inflammation).pptx
PPTX
Emergencies in Anaesthesia by Dr SAMI.pptx
PPTX
Bronchial Asthma2025 GINA Guideline.pptx
PPTX
FORENSIC MEDICINE and branches of forensic medicine.pptx
PPTX
PSYCHIATRIC SEQUALAE OF HEAD INJURY.pptx
PPTX
critical care nursing 12.pptxhhhhhhhhjhh
PPTX
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
PDF
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
PPTX
Phamacology Presentation (Anti cance drugs).pptx
PPTX
Approch to weakness &paralysis pateint.pptx
PDF
Diabetes mellitus - AMBOSS.pdf
PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
A Detailed Physiology of Endocrine System.pptx
ACUTE PANCREATITIS combined.pptx.pptx in kids
Approach to Abdominal trauma Gemme(COMMENT).pptx
Seizures and epilepsy (neurological disorder)- AMBOSS.pdf
BONE-TYPES,CLASSIFICATION,HISTOLOGY,FRACTURE,
Geriatrics_(0).pptxxvvbbbbbbbnnnnnnnnnnk
Nutrition needs in a Surgical Patient.pptx
Indications for Surgical Delivery...pptx
المحاضرة الثالثة Urosurgery (Inflammation).pptx
Emergencies in Anaesthesia by Dr SAMI.pptx
Bronchial Asthma2025 GINA Guideline.pptx
FORENSIC MEDICINE and branches of forensic medicine.pptx
PSYCHIATRIC SEQUALAE OF HEAD INJURY.pptx
critical care nursing 12.pptxhhhhhhhhjhh
SUMMARY OF EAR, NOSE AND THROAT DISORDERS INCLUDING DEFINITION, CAUSES, CLINI...
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
Phamacology Presentation (Anti cance drugs).pptx
Approch to weakness &paralysis pateint.pptx
Diabetes mellitus - AMBOSS.pdf
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt

Nephrotic syndrome Undergaraduate

  • 1. Dr Ashutosh Ojha Reader, Internal Medicine 17 Feb2016Dr A Ojha
  • 2.  Clinical complex characterized by a number of renal and extra renal features.The most prominent being.  Proteinuria of > 3.5 g/d  Hypoalbuminaemia  Oedema  Hyperlipidaemia  Hypercoagulability. 17 Feb2016Dr A Ojha
  • 3.  Key component is proteinuria ◦ Results from altered permeability of glomerular filtration barrier(GBM,podocytes& their slit diaphragm) for proteins ◦ All other metabolic complications are secondary to urine protein loss. 17 Feb2016Dr A Ojha
  • 4. Proteinuria Loss of lipid metabolism Sr Albumin regulating protein Oncotic pressure Oedema Hepatic lipoprotein synthesis Hyperlipdaemia 17 Feb2016Dr A Ojha
  • 5.  Altered level of Urinary loss of protein C and S Antithrombin III  Hyperfibrinogenaemia  Impaired fibrinolysis   Platelet aggregability Hypercoagulability Peripheral arterial and venous thrombosis Renal vein thrombosis Pulmonary embolism 17 Feb2016Dr A Ojha
  • 6.  Other metabolic complications. ◦ Protein malnutrition ◦ Iron resistant microcytic hypochromic anaemia ◦ Hypocalcaemia ◦ Vit D deficiency ◦ Secondary hypoparathyroidism ◦  thyroxin levels ◦  IgG 17 Feb2016Dr A Ojha
  • 7.  Damage to GBM o  Number & size of pores Passage of more and larger proteins o  in fixed negatively charged components ( Repel negatively charged protein molecules ) 17 Feb2016Dr A Ojha
  • 9.  6 entities account for >90% in adults ◦ Minimal change disease(MCD) ◦ Focal & segmental glomerulosclerosis(FSGS) ◦ Membranous glomerulopathy. ◦ Membrnoproliferative GN (MPGN). ◦ Diabetic nephropathy. ◦ Amyloidosis 17 Feb2016Dr A Ojha
  • 10.  Systemic vasculitis eg-SLE  Drugs ◦ Penicillamine ◦ Captopril ◦ Gold ◦ Cadmium  Allergic reactions ◦ Pollens ◦ Bee sting 17 Feb2016Dr A Ojha
  • 11.  History. ◦ Frothy urine –heavy proteinuria ◦ Oedema-Periorbital,arms.ascites,genital oedema. ◦  BP in some. ◦ Features of underlying disease viz SLE,DM ◦ Rule out  Primary cardiac failure  Chronic liver disease 17 Feb2016Dr A Ojha
  • 12.  Diagnosis established by ◦ 24 hr urinary protein >3.5g/day ◦ Sr Albumin <3g/dl 17 Feb2016Dr A Ojha
  • 13.   Cholesterol,  LDL,  triglycerides   Urea, Creatinine ---- progressive disease  Urine microscopy—RBC,RBC casts  Throat swab Streptococcal infection  ASO titer  C3 level-immune complex mediated  ANA  HBsAg&HCAntibodies  Cryoglbulinaemia  17 Feb2016Dr A Ojha
  • 14.  Sr electrophoresis - MM   Blood glucose.—DM  Selective proteinuria—MCD,diabetic nephropathy,amyloidosis.  Non selective proteinuria—Diffuse proliferative GN 17 Feb2016Dr A Ojha
  • 15.  Gradual onset of acute renal failure  No obvious cause of acute renal failure  Heavy proteinuria  Significant haematuria  Clinical evidence or history of systemic disease  Prolonged oliguria 17 Feb2016Dr A Ojha
  • 16.  Not required in ◦ Young children with highly selective proteinuria,no HTN,no red cells or red cell casts in urine ◦ Long standing insulin dependent diabetes mellitus ◦ On drugs like penicillamine. 17 Feb2016Dr A Ojha
  • 17.  Specific treatment of underlying cause.  Drugs- immunosuppressive therapy.  General measures to control proteinuria.  General measures to control complications. 17 Feb2016Dr A Ojha
  • 18.  80% cases < 16yrs, 20% cases in adults.  Peak incidence 6-8yrs  Idiopathic.  Occurrence after URTI, immunization.   incidence in HLA B12.  May be associated with interstitial nephritis, lymphomas. 17 Feb2016Dr A Ojha
  • 19.  High mol wt proteinuria.  Benign urinary sediment.  Microscopic haematuria in 20-30% cases.  HTN & RF -----rare 17 Feb2016Dr A Ojha
  • 20.  Glomerular size & structure – normal in light microscopy.  Immunoflorescense studies –neg for Ig & C3  Electron microscopy  Diffuse effacement of foot processes of visceral epithelial cells. 17 Feb2016Dr A Ojha
  • 22.  Highly steroid responsive .  Excellent prognosis.  Spontaneous remission in 30-40% children.  Remission with 8 wks of high dose glucocorticoids in 90% of children, 50% of adults. 17 Feb2016Dr A Ojha
  • 23. Dose  Children: 60 mg/mt2/day x 4 wks 40 mg/mt2/day x 4 wks Adults: 1.15mg/kg/day x 4 wks 1mg/kg/day x 4 wks  50% relapse fallowing withdrawal. 17 Feb2016Dr A Ojha
  • 24.  Relapse during / shortly after withdrawal  Relapse - >3 / yr Cyclophosphamide- 2-3 mg/ kg /day 8 –12 wks or Chlormabucil- 0.1-0.2 mg/ kg /day 8 –12 wks  Side effects-infertility, cystitis, alopecia, infections, sec malignancies.  Cyclosporin can be tried in those resistant to above . 17 Feb2016Dr A Ojha
  • 25.  Sclerosis with hyalinosis involving portions of < 50% glomeruli in a tissue section.  1/3 cases of nephrotic syndrome in males.  Proteinuria with HTN and mild renal insufficiency. 17 Feb2016Dr A Ojha
  • 27.  Spontaneous remission rare.  Prognosis poor.  Drug therapy unsatisfactory.  Renal transplant. 17 Feb2016Dr A Ojha
  • 28.  30-40% of NS in adults.  Rare in children.  Peak incidence 30-50 yrs.  1/3 rd assocition with systemic diseases like SLE, infections, malignancy, HBV, drugs. 17 Feb2016Dr A Ojha
  • 30.  Light microscopy- diffuse thickening of GBM with e/o cellular infiltration.  Electron microscopy- immune deposits of IgG & C3 17 Feb2016Dr A Ojha
  • 31.  Proteinuria- non selective  Microscopic hematuria in 50%.  RBC casts, leukocytes, macroscopic hematuria are rare.  HTN 10-30%.  40% remit spontaneously, 10-20% slowly progressive ESRD, others remit & relapse. 17 Feb2016Dr A Ojha
  • 32.  Steroids- unsatisfactory.  Cytotoxic drugs- some benefit. 17 Feb2016Dr A Ojha
  • 33.  Features -Thickening of GBM - proliferative changes. -diffuse increase in mesangial cells and matrix. -immune deposits- C3, IgG, IgM, IgA. 17 Feb2016Dr A Ojha
  • 34.  In association with -IE -HIV -HBV, HCV -Cryoglobulinaemia -Lymphoma 17 Feb2016Dr A Ojha
  • 35.  Heavy proteinuria  Active urinary sediment  Normal to mildly impaired renal function.  Course- benign to ESRD.  No effective treatment. 17 Feb2016Dr A Ojha
  • 36.  ACE inhibitors- act by ↓ intraglomerular pressure and prevent hemodynamically mediated focal segmental glomerulosclerosis. Specially in DM, FSGS.  NSAIDS- act by altering glomerular hemodynamics& permeability. 17 Feb2016Dr A Ojha
  • 37.  Edema- salt restriction 1-2 gms/ day  Loop diuretics  Hyperlipidaemia- statins  Thromboembolism- anticoagulation.  Malnutrition- ? High protein diet.  Vitamins D supplements 17 Feb2016Dr A Ojha